Luisa Politano Selected Research

MD1

1/2013	Does a high percentage of right ventricular pacing influence the incidence of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients?
4/2012	The effect of atrial preference pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: a prospective, randomized, single-bind cross-over study.
9/2010	Does Bachmann's bundle pacing prevent atrial fibrillation in myotonic dystrophy type 1 patients? A 12 months follow-up study.
9/2009	Right atrial appendage versus Bachmann's bundle stimulation: a two-year comparative study of electrical parameters in myotonic dystrophy type-1 patients.
11/2008	Optimal site for atrial lead implantation in myotonic dystrophy patients: the role of Bachmann's Bundle stimulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luisa Politano Research Topics

Disease

13	Myotonic Dystrophy (Dystrophia Myotonica) 06/2020 - 11/2008
11	Muscular Dystrophies (Muscular Dystrophy) 12/2021 - 04/2003
10	Muscular Diseases (Myopathy) 06/2022 - 09/2011
7	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 03/2021 - 04/2003
7	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 01/2018 - 03/2004
6	Heart Failure 01/2021 - 04/2003
4	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2021 - 04/2003
4	Atrial Fibrillation 12/2019 - 09/2010
4	Cardiomyopathies (Cardiomyopathy) 01/2019 - 06/2012
3	Protein Deficiency 01/2019 - 01/2005
3	Fibrosis (Cirrhosis) 01/2018 - 12/2009
3	Rare Diseases (Rare Disease) 10/2016 - 07/2014
3	Glycogen Storage Disease Type II (Pompe's Disease) 01/2015 - 12/2011
2	COVID-19 12/2021 - 09/2021
2	Disease Progression 12/2021 - 07/2014
2	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 11/2020 - 01/2019
2	Tachycardia (Tachyarrhythmias) 06/2020 - 01/2013
2	Cataract (Cataracts) 06/2020 - 12/2009
2	Sarcoglycanopathies 01/2020 - 04/2015
2	X-Linked Emery-Dreifuss Muscular Dystrophy 11/2019 - 03/2010
2	Emery-Dreifuss Muscular Dystrophy (Scapuloperoneal Muscular Dystrophy) 01/2018 - 06/2012
1	Bethlem myopathy 06/2022
1	Scleroatonic muscular dystrophy 06/2022
1	Muscle Weakness 12/2021
1	Fabry Disease (Fabry's Disease) 07/2021
1	Scoliosis 03/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2021
1	Neuromuscular Diseases (Neuromuscular Disease) 06/2020
1	Laminopathies 01/2020
1	Death (Near-Death Experience) 01/2019
1	Ventricular Dysfunction 12/2018
1	Myotonia Congenita (Thomsen Disease) 01/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2018
1	Walker-Warburg Syndrome 01/2018
1	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 01/2018
1	Atrophy 12/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016
1	Arrhythmogenic Right Ventricular Dysplasia (Arrhythmogenic Right Ventricular Cardiomyopathy) 12/2015
1	Muscle Cramp (Cramp) 05/2015
1	Myoglobinuria 05/2015

Drug/Important Bio-Agent (IBA)

11	DystrophinIBA 12/2021 - 06/2008
7	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2013
5	Proteins (Proteins, Gene)FDA Link 03/2021 - 07/2014
5	MD1IBA 01/2013 - 11/2008
4	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 07/2005
3	DysferlinIBA 01/2015 - 09/2011
2	Dystroglycans (Dystroglycan)IBA 01/2018 - 01/2016
2	Sarcoglycans (beta Sarcoglycan)IBA 04/2015 - 11/2011
2	Caveolin 3IBA 06/2012 - 01/2005
1	CollagenIBA 06/2022
1	atalurenIBA 12/2021
1	VaccinesIBA 09/2021
1	GlycosphingolipidsIBA 07/2021
1	GalactosidasesIBA 07/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2021
1	omega-Chloroacetophenone (Mace)IBA 01/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2021
1	Nonsense Codon (Nonsense Mutation)IBA 01/2021
1	nusinersenIBA 11/2020
1	Local AnestheticsIBA 06/2020
1	Ropivacaine (Naropin)FDA LinkGeneric 06/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	Interleukin-4 (Interleukin 4)IBA 01/2020
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020
1	CytokinesIBA 01/2020
1	Interleukin-8 (Interleukin 8)IBA 01/2020
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2020
1	ChemokinesIBA 01/2020
1	Troponin IIBA 12/2019
1	MB Form Creatine KinaseIBA 12/2019
1	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2019
1	pro-brain natriuretic peptide (1-76)IBA 12/2019
1	Androgen Receptors (Androgen Receptor)IBA 11/2019
1	Albuterol (Salbutamol)FDA LinkGeneric 01/2019
1	AngiotensinsIBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Angiotensin IIIBA 01/2018
1	Chloride Channels (Chloride Channel)IBA 01/2018
1	ConnectinIBA 01/2018
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2018
1	CLC-1 channelIBA 01/2018
1	mannose 1-phosphate guanylyltransferaseIBA 01/2018
1	Amino Acids FDA Link 01/2018
1	Guanosine Diphosphate Mannose (GDP Mannose)IBA 01/2018
1	Follicle Stimulating Hormone (Follitropin)FDA Link 12/2017
1	Hormones (Hormone)IBA 12/2017
1	Lamin Type A (Lamin A)IBA 12/2015
1	GlucocorticoidsIBA 10/2015
1	Phosphotransferases (Kinase)IBA 05/2015
1	Indicators and Reagents (Reagents)IBA 12/2014

Therapy/Procedure

10	Therapeutics 12/2021 - 12/2013
3	Heart Transplantation (Grafting, Heart) 01/2019 - 05/2017
2	Defibrillators (Defibrillator) 01/2019 - 03/2010
2	Noninvasive Ventilation 10/2014 - 12/2012
1	Continuity of Patient Care 12/2021
1	Ambulatory Care (Outpatient Care) 09/2021
1	Local Anesthesia 06/2020
1	Aftercare (After-Treatment) 10/2014